YAZ/YASMIN/OCELLA, GIANVI & BEYAZ CASES ARE NOW SETTLING! TO SEE IF YOU QUALIFY CALL Toll FREE (844)561-0000 RIGHT NOW. That is (844) 587-8423.
If you sustained a DVT, SVT, PE, Stroke or Lost a Loved One who was on Yaz, Yasmin Ocella, Gianvi or BeYaz from 2001-2012 you may be eligible for compensation. (We are sorry we can no longer accept Gall Bladder injuries).
How did I get a Pulmonary Embolism (PE)? Can my hormonal birth control like Gianvi, Ocella, Yaz or Yasmin cause a DVT (Deep Vein Thrombosis)? How did I get a Sagittal Venous Thrombosis or Superficial Venous Thrombosis (SVT?) These are some common questions clients ask and are in disbelief when they find out the fourth generation of birth control is less safe than the earlier generations.
After a hard fought litigation women who took Yaz, Yasmin, Ocella, or Gianvi may be entitled to compensation if they endured a thrombotic event, also known as a “blood clot” and had a DVT, Stroke, PE or death. The case is coming to a close, and the sooner you speak with a professional the better off you are to protect your rights.
If you aren’t 100% sure of which birth control you took and you sustained an injury, we still will gather your medical records at no expense to you. We are only paid if we win your case. If we gather your records and find out you don’t have a case you don’t owe us anything.
A common indicator that you may have had a thrombotic event from Gianvi, Yasmin, Yaz or Ocella, like a DVT, SVT, or PE is the use of blood thinners like Coumadin, Heparin, Lovenox or even Xarelto.
Call us 24/7 at (844) 561-0000 to discuss your case.
Yaz or Yasmin
Yaz and Yasmin were commonly prescribed as the latest and greatest birth controls, but unfortunately despite the over promotion, they also carried a deeper risk of having a Yasmin DVT, Yasmin PE, Yasmin SVT, and likewise a YAZ DVT, YAZ PE, YAZ SVT, strokes and death. If you took Yaz or Yasmin and experienced blood clots, loss of vision, stroke, heart attack, pulmonary embolism, deep vein thrombosis or any other thrombotic event you may be entitled to compensation as a result. If you’re presently on Yaz or Yasmin and you have any symptoms of a VTE you should consult with a health care professional immediately.
Beyaz is a newer version of Yaz and Yasmin that included a folate supplement. It was approved by the FDA in September 2010 despite concerns about potential risk of blood clots from drospirenone birth control pills.
When Beyaz was approved Yaz and Yasmin occupied 25% of the market, although sales have fallen amidst competition from generic pills while questions surrounded Yaz and Yasmin side effects and its link to blood clots and other thrombotic events.
According to research the increased risk of blood clots exists with Beyaz just like its predecessors. The pills were the first to raise folate levels in women, with each pill containing 451 mcg of levomefolate calcium but of little consequence to a measurable difference in risk.
CASES ARE NOW SETTLING! TO SEE IF YOU QUALIFY CALL (844) 561-0000 RIGHT NOW.
Or Click (877) 561-0000 on your mobile browser to call. You can also Text (201) 212-6000
Lawsuits have been filed on the grounds that Bayer Healthcare Pharmaceuticals failed to disclose the harmful side effects of their drug, which is known to contain Drospirenone. This chemical is known to increase the risk of blood clots – which may result in any of the above mentioned side effects.
Bayer Healthcare has started settling many of the cases out of court.
We will FIGHT FOR YOUR RIGHTS, for your just compensation, in regards to the negligence of Bayer Healthcare. If you have taken Yaz, Yasmin, BeYaz, Ocella or Gianvi and you suffered a thromboembolic event from 2001-2012 you may be eligible for compensation. Please contact us via phone or our contact box, in order to have an attorney contact you ASAP to discuss your rights.
The head of our firm Jason T. Brown is a pioneer in birth control litigation. Our firm can explain your rights, the legal process, and the potential awards you may receive as a result of taking Yaz, Yasmin, Ocella or Gianvi. They can also more closely explain the link between these serious health conditions and the taking of the birth control drugs. Selection of an attorney is a critical decision and having an attorney who has already settled other cases may be beneficial during the Yaz Settlement phase.
When the Federal Drug Administration became concerned regarding the associated risks of the active ingredient in Yaz, Yasmin, Ocella, Gianvi, and Beyaz, known as drospirenone, they started several studies concerning the side effects associated with it. This led to the statistics that the risk for venous thromboembolic events (or fatal blood clots) was raised 93% in patients who had been taking Yaz or Yasmin for up to 6 months. Over 6 months jumped the risk to the point of being 290% higher. As a result in April 2012, the FDA mandated labeled warnings that profess the harsh risk of developing blood clots as a result of taking the drug.
More than a billion dollars has been paid towards settling the Yaz litigation. Bayer Healthcare has already alerted it’s stockholders that there are more pending settlements, and has taken the preemptive decision to set aside money towards the final settlements.
- Lawsuits Stemming from the Use of Safyral
- Safyral Investigated by the FDA
While virtually all contraceptives carry a certain risk of side effects, the ones associated with Safyral use are particularly serious and in fact, warranted an investigation by the U.S. Food and Drug Administration. Safyral, like many other oral contraceptives that contain drospirenone as a primary active ingredient have been under fire for their tendency to cause blood clots. These complaints have become so widespread–and the resulting lawsuits so prevalent–that the FDA has requested the manufacturers of the drug to update the label of Safyral.
One of the most significant investigations into the potentially harmful effects of Safyral use was an advisory panel organized by the FDA in December 2011. This panel was formed to investigate the links between certain health conditions–particularly blood clotting–and oral contraceptives containing drospirenone. In addition to Safyral the medications under study were Yasmin, Yaz, and Beyaz. All of these medications are manufactured by Bayer AG; and all have been suspected of increasing the risk of blood clots in women who have taken the medication.
Although the panel determined that the benefits of these types of drugs still outweighed their risk, it did stop short of proclaiming the drug totally safe. The results of the vote to determine the benefits of the drug versus its risks were also telling: 15 to 11. Perhaps due to the closeness of the results and the fact that there are older types of oral contraceptives that provide the same benefits as drospirenone-based medications without the risks, the panel overwhelmingly voted for the updating of the labels of these medications, in order to warn the public on no uncertain terms about the risks of taking these drugs.
- Was Bayer aware of Safyral risks?
Further swaying public opinion against Bayer is the fact that the company was apparently aware of blood clots possibly caused by the use of drospirenone-based drugs, but did not bring them to the attention of the FDA prior to seeking approval. Unfortunately, these kinds of concealment practices are fairly commonplace in the drug industry, and also the risks inherent in certain medications may be apparent to the manufacturers, it is only when the lawsuits begin to pile up that these manufacturers acknowledge them.